Purdue Seeks Equity In Abuse/Misuse Labeling For Immediate-Release Opioids
This article was originally published in The Pink Sheet Daily
Executive Summary
The manufacturer of extended-release oxycodone contends in a citizen petition that immediate-release and extended-release/long-acting opioid analgesics contain the same active ingredients and pose a similar risk of abuse, misuse and overdose.